What is the Impact Factor of Cancer Chemotherapy and Pharmacology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Chemotherapy and Pharmacology is 2.50, ranking in quartile Q3 of Web of Science (SCIE).

Is Cancer Chemotherapy and Pharmacology indexed in Web of Science or Scopus?

Yes, Cancer Chemotherapy and Pharmacology is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.851 (Q2) and an H-index of 132.

Who publishes Cancer Chemotherapy and Pharmacology and what is the Article Processing Charge (APC)?

Cancer Chemotherapy and Pharmacology is published by Springer Berlin Heidelberg. The estimated Article Processing Charge (APC) is approximately $3,245 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Chemotherapy and Pharmacology?

The official ISO-4 abbreviation of Cancer Chemotherapy and Pharmacology is "CANCER CHEMOTH PHARM" with common acronym "ccap". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #6,299Hybrid

Cancer Chemotherapy and Pharmacology

Acronym:ccap

•

Abbreviation (ISO):CANCER CHEMOTH PHARM

•

Identifier (ISSN):0344-5704(Print)/1432-0843(Online)

•

Publisher:Springer Berlin Heidelberg

Official Website Submission Portal Compare

Clarivate IF (2026)

2.5↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Chemotherapy and Pharmacology

WoS Q3

Annual Impact Factor Metric

Current (2026):2.5

Scopus SJR & RankScopus Q2

0.851

#6,299

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

132

132 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate3.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

162articles/year

34.66% Gold OA•92.17% Original Research

Aims & Scope

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

Topics Covered (Recognized by AI)

Medicine99.1%Biology98.4%Internal medicine95.3%Genetics93%Chemistry80%Surgery70.9%Chemotherapy62.8%Pharmacology59.9%Biochemistry56.3%Cancer54.6%Organic chemistry50.4%Pathology43.5%Bioinformatics37.1%Oncology34.1%Toxicity30.2%Endocrinology29.6%Cancer research28.7%Immunology28.4%Pharmacokinetics27.3%Gastroenterology25.6%In vitro21.6%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank204/333

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank205/356

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank185/333

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank202/356

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	204/333	Q3
PHARMACOLOGY & PHARMACY	JCRSCIE	205/356	Q3
ONCOLOGY	JCISCIE	185/333	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	202/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.5

Articles / Year107

Total Citations37

2025

IF2.3

Articles / Year112

Total Citations238

2024

IF2.7

Articles / Year109

Total Citations464

2023

IF3

Articles / Year126

Total Citations1,011

2022

IF3.288

Articles / Year125

Total Citations1,324

Year	Impact Factor	Articles / Year	Total Citations
2026	2.5	107	37
2025	2.3	112	238
2024	2.7	109	464
2023	3	126	1,011
2022	3.288	125	1,324
2021	3.333	173	2,682
2020	2.967	184	3,175
2019	3.008	252	5,703
2018	2.808	247	5,681
2017	—	279	8,261
2016	—	271	9,177
2015	—	279	7,699

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,299Scopus Q2SCImago Profile

Scopus Coverage:1978-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.851

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.44

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,245 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations902

3-Year Documents351

Citable Documents345

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2

PharmacologyQ2

Pharmacology (medical)Q2

ToxicologyQ2

Cancer ResearchQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Chemotherapy and Pharmacology (acronym: ccap, abbr: CANCER CHEMOTH PHARM, ISSN: 0344-5704) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Berlin Heidelberg in United States since 1978. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.851 (Q2), an H-index of 132.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 162 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,245 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.